Näslund E, Andersson I, Degerblad M, Kogner P, Kral J G, Rössner S, Hellström P M
Division of Surgery, Danderyd Hospital, Sweden.
J Intern Med. 2000 Oct;248(4):299-308. doi: 10.1046/j.1365-2796.2000.00737.x.
The aim of the present study was to identify predictors of weight loss in obese men participating in a 2-year behaviour modification programme.
Longitudinal, clinical intervention study of a behaviour modifying weight loss program.
University Hospital, Stockholm, Sweden.
Forty-four obese men (age, 42.7 +/- 1.1 years: BMI, 37.1 +/- 0.6 kg m(-2), mean +/- SEM) followed for 2 years.
Behaviour modification weight loss programme.
Associations between plasma leptin and thyroid function tests, insulin resistance by homeostatic model assessment (HOMA), dietary recall and anthropometrically determined body composition.
At baseline, there were significant correlations between plasma leptin and body mass index (BMI), fat-free mass (FFM) and insulin resistance. Median weight loss over 2 years was 4.9 kg (range, -27.2 to +11.9). Baseline serum leptin concentrations adjusted for BMI (leptin/BMI ratio) were significantly correlated with 2-year weight change (r = 0.34, P = 0.04). A subset of seven of the 44 men gained weight over the 2 years. These 'gainers' differed significantly in initial leptin/BMI ratio (0.62 +/- 0.07) compared with the 37 'losers' (0.42 +/- 0.03, P < 0.05). In a multiple regression model, baseline leptin, insulin and age predicted 22% of the variance in weight change with no additional significant contribution from BMI, FFM, waist:hip ratio, thyroid function tests or energy intake. There was a strong correlation between the change in leptin concentrations and the change in insulin resistance from baseline to 2-year follow-up (r = 0.54; P < 0.001).
Baseline plasma leptin concentrations predicted long-term weight loss. Inappropriate leptin secretion or disposal, corrected for BMI, was associated with failure to maintain weight loss in obese men in a behaviour modification weight loss programme.
本研究旨在确定参与一项为期2年行为矫正计划的肥胖男性体重减轻的预测因素。
一项关于行为矫正减肥计划的纵向临床干预研究。
瑞典斯德哥尔摩的大学医院。
44名肥胖男性(年龄42.7±1.1岁;体重指数37.1±0.6kg/m²,均值±标准误),随访2年。
行为矫正减肥计划。
血浆瘦素与甲状腺功能检查、通过稳态模型评估(HOMA)得出的胰岛素抵抗、饮食回忆及通过人体测量确定的身体成分之间的关联。
在基线时,血浆瘦素与体重指数(BMI)、去脂体重(FFM)及胰岛素抵抗之间存在显著相关性。2年期间体重减轻的中位数为4.9kg(范围为-27.2至+11.9)。经BMI校正后的基线血清瘦素浓度(瘦素/BMI比值)与2年体重变化显著相关(r=0.34,P=0.04)。44名男性中有7名在2年期间体重增加。这些“体重增加者”的初始瘦素/BMI比值(0.62±0.07)与37名“体重减轻者”(0.42±0.03,P<0.05)相比有显著差异。在多元回归模型中,基线瘦素、胰岛素和年龄可预测体重变化中22%的方差,BMI、FFM、腰臀比、甲状腺功能检查或能量摄入无额外显著贡献。从基线到2年随访期间,瘦素浓度变化与胰岛素抵抗变化之间存在强相关性(r=0.54;P<0.001)。
基线血浆瘦素浓度可预测长期体重减轻。经BMI校正后,不适当的瘦素分泌或处理与肥胖男性在行为矫正减肥计划中未能维持体重减轻有关。